EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Range of Resection in Endometrial Cancer—Clinical Issues of Made-to-Measure Surgery

Agnieszka Horala iD, Sebastian Szubert iD, Ewa Nowak-Markwitz

Cancers · 11.05.2024 · 16 (10) · 1848

DOI: 10.3390/cancers16101848 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.05.2024. Verfasst von Agnieszka Horala und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynaecological Oncology, Department of Gynaecology, Poznan University of Medical Sciences, 61-701 Poznan, Poland. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial cancer (EC) poses a significant health issue among women, and its incidence has been rising for a couple of decades. Surgery remains its principal treatment method and may have a curative, staging, or palliative aim. The type and extent of surgery depends on many factors, and the risks and benefits should be carefully weighed. While simple hysterectomy might be sufficient in early stage EC, modified-radical hysterectomy is sometimes indicated. In advanced disease, the evidence suggests that, similarly to ovarian cancer, optimal cytoreduction improves survival rate. The role of lymphadenectomy in EC patients has long been a controversial issue. The rationale for systematic lymphadenectomy and the procedure of the sentinel lymph node biopsy are thoroughly discussed. Finally, the impact of the molecular classification and new International Federation of Gynecology and Obstetrics (FIGO) staging system on EC treatment is outlined. Due to the increasing knowledge on the pathology and molecular features of EC, as well as the new advances in the adjuvant therapies, the surgical management of EC has become more complex. In the modern approach, it is essential to adjust the extent of the surgery to a specific patient, ensuring an optimal, made-to-measure personalized surgery. This narrative review focuses on the intricacies of surgical management of EC and aims at summarizing the available literature on the subject, providing an up-to-date clinical guide.

Schlagwörter

Stichwörter der Autor:innen

endometrial cancerendometrial neoplasmsgynecologic cancerlymphadenectomymolecular subtypessentinel lymph nodesurgeryuterine cancer

Autor:innen und Institutionen

  • Division of Gynaecological Oncology, Department of Gynaecology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

ORCID-Profile: Agnieszka Horala, Sebastian Szubert

Zitieren

APA

Horala, A., Szubert, S., & Nowak-Markwitz, E. (2024). Range of Resection in Endometrial Cancer—Clinical Issues of Made-to-Measure Surgery. Cancers, 16(10), 1848. https://doi.org/10.3390/cancers16101848

Vancouver

Horala A, Szubert S, Nowak-Markwitz E. Range of Resection in Endometrial Cancer—Clinical Issues of Made-to-Measure Surgery. Cancers. 2024;16(10):1848. doi:10.3390/cancers16101848

BibTeX
@article{Horala2024,
  author = {Horala, Agnieszka and Szubert, Sebastian and Nowak-Markwitz, Ewa},
  title = {Range of Resection in Endometrial Cancer—Clinical Issues of Made-to-Measure Surgery},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {1848},
  doi = {10.3390/cancers16101848}
}
Kostenlos starten →